X
Xavier Chevalier
Researcher at Paris 12 Val de Marne University
Publications - 239
Citations - 7029
Xavier Chevalier is an academic researcher from Paris 12 Val de Marne University. The author has contributed to research in topics: Osteoarthritis & WOMAC. The author has an hindex of 41, co-authored 227 publications receiving 6043 citations. Previous affiliations of Xavier Chevalier include University of Paris.
Papers
More filters
Journal ArticleDOI
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
Xavier Chevalier,Philippe Goupille,André D. Beaulieu,F. X. Burch,William G. Bensen,Thierry Conrozier,Damien Loeuille,Alan Kivitz,David S. Silver,B. E. Appleton +9 more
TL;DR: Anakinra was well tolerated as a single 50-mg or 150-mg intraarticular injection in patients with OA of the knee, however, anakinRA was not associated with improvements in OA symptoms compared with placebo.
Journal ArticleDOI
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Jean-Yves Reginster,J. Badurski,Nicholas Bellamy,William G. Bensen,Roland Chapurlat,Xavier Chevalier,Claus Christiansen,Harry K. Genant,Federico Navarro,Evgeny Nasonov,Philip N. Sambrook,Tim D. Spector,Cyrus Cooper +12 more
TL;DR: In this paper, a double-blind, randomised, placebo-controlled Strontium ranelate Efficacy in Knee OsteoarthrItis triAl evaluated its effect on radiological progression of knee osteoarthritis.
Journal ArticleDOI
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
Xavier Chevalier,Joerg Jerosch,Philippe Goupille,C.N. van Dijk,Frank P. Luyten,David Scott,François Bailleul,Karel Pavelka +7 more
TL;DR: This placebo-controlled study demonstrated that, in patients with knee osteoarthritis, a single 6 ml intra-articular injection of hylan G-F 20 is safe and effective in providing statistically significant, clinically relevant pain relief over 26 weeks, with a modest difference versus placebo.
Journal ArticleDOI
A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis
Francis Berenbaum,Joachim Grifka,Sara Cazzaniga,Massimo D'Amato,Giampaolo Giacovelli,Xavier Chevalier,François Rannou,Lucio C. Rovati,Emmanuel Maheu +8 more
TL;DR: Treatment with 3-weekly injections of intermediate MW HA may be superior to low MW HA on knee OA symptoms over 6 months, with similar safety.
Journal ArticleDOI
Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis
Pascal Richette,Christine Poitou,Patrick Garnero,Eric Vicaut,Jean-Luc Bouillot,Jean-Marc Lacorte,Arnaud Basdevant,Karine Clément,Thomas Bardin,Xavier Chevalier +9 more
TL;DR: In this article, the effect of massive weight loss on knee pain and disability, low-grade inflammation and metabolic status and joint biomarkers in obese patients with knee osteoarthritis (OA) was investigated.